Cleared Traditional

K902237 - MEDICA IIF ANTI-SKIN ANTIBODY TEST KIT

K902237 is the FDA 510(k) clearance for MEDICA IIF ANTI-SKIN ANTIBODY TEST KIT by Medica Corp.. It is a Class 2 Immunology device (product code DBL) cleared through the Traditional 510(k) pathway after a 52-day FDA review.

K902237 · Medica Corp. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1990
Decision
52d
Days
Class 2
Risk

K902237 is an FDA 510(k) clearance for the MEDICA IIF ANTI-SKIN ANTIBODY TEST KIT. Classified as Multiple Autoantibodies, Indirect Immunofluorescent, Antigen, Control (product code DBL), Class II - Special Controls.

Submitted by Medica Corp. (Carlsbad, US). The FDA issued a Cleared decision on July 9, 1990 after a review of 52 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5660 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Medica Corp. devices

Submission Details

510(k) Number K902237 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 18, 1990
Decision Date July 09, 1990
Days to Decision 52 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
52d faster than avg
Panel avg: 104d · This submission: 52d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DBL Multiple Autoantibodies, Indirect Immunofluorescent, Antigen, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5660
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - DBL Multiple Autoantibodies, Indirect Immunofluorescent, Antigen, Control

Devices cleared under the same product code (DBL) and FDA review panel - the closest regulatory comparables to K902237.
Histofluor Rodent LKS Fluorescent Antibody Test System, Image Navigator by Immuno Concepts
K180202 · Immuno Concepts, N.A. , Ltd. · Oct 2018
NOVA LITE ENDOMYSIAL
K980312 · Inova Diagnostics, Inc. · Apr 1998
RIT LIVER, KIDNEY, STOMACH IFA KIT
K955431 · The Binding Site, Ltd. · Apr 1996
ANTI-SKIN ANTIBODY TEST SYSTEM
K811261 · Zeus Scientific, Inc. · Aug 1981
KALLESTAD FLORESCENT ANA/AMA/ASMA TEST
K792610 · Kallestad Laboratories, Inc. · Feb 1980